Results 281 to 290 of about 402,863 (300)

A Phase 3 Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2014
Lisa H Lancaster, Steven D Nathan, Jeffrey J Swigris   +2 more
exaly  

Effect of interferon gamma-1b on survival in patients with idiopathic pulmonary fibrosis (INSPIRE): a multicentre, randomised, placebo-controlled trial

Lancet, The, 2009
Talmadge E King Jr, Carlo Albera, dominique Valeyre   +2 more
exaly  

Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2014
Luca Richeldi, Ganesh Raghu, Arata Azuma
exaly  

Idiopathic pulmonary fibrosis

Allergy, 2005
Harari S., Caminati A.
openaire   +2 more sources

New cellular and molecular mechanisms of lung injury and fibrosis in idiopathic pulmonary fibrosis

Lancet, The, 2012
Isis E Fernandez, Oliver Eickelberg
exaly  

Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2011
Luca Richeldi, Ulrich Costabel, Moisés Selman   +2 more
exaly  

Diffuse Pulmonary Fibrosis

Proceedings of the Royal Society of Medicine, 1932
F P, Weber, O B, Bode
openaire   +2 more sources

Emerging therapies for idiopathic pulmonary fibrosis, a progressive age-related disease

Nature Reviews Drug Discovery, 2017
Ana L Mora, Mauricio Rojas, Annie Pardo
exaly  

A Controlled Trial of Sildenafil in Advanced Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2010
Bethany B Moore
exaly  

A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis

New England Journal of Medicine, 2004
Ganesh Raghu, David A Schwartz, Talmadge E King Jr   +2 more
exaly